COVID-19: Vaccines and Therapeutics
The Food and Drug Administration today expanded its approval for remdesivir (Veklury) to include pediatric patients under age 12 who test positive for SARS-CoV-2 and are hospitalized or at high risk of progressing to severe COVID-19. The patient must be at least 28 days old and weigh at least…
Unvaccinated children aged 5-11 were twice as likely as vaccinated children to be hospitalized for COVID-19 in the first few months of the omicron wave, the study found.
FDA and HHS authorized extending the shelf life for certain products stored at the right temperatures.
The summit will feature conversations with medical professionals, parents and community leaders on how the medical community can encourage vaccination among pregnant people, children, teens and young adults.
With mask restrictions lifting as a new omicron variant emerges, an Allina Health infectious disease expert takes to the airwaves, encouraging people to get a first or second COVID-19 vaccine booster.
Amid new variants and lifted restrictions, an Allina Health infectious disease expert encourages…
The trial included 140 children who received the booster about 6 months after completing the primary vaccine series.
In a study of adults previously infected with COVID-19, the Pfizer and Moderna COVID-19 vaccines offered additional protection against reinfection leading to hospitalization.
The agency last week extended the J&J vaccine's shelf life and authorized two COVID-19 tests.
Experts from Duke Health explain how the COVID-19 vaccine is moving the nation toward endemicity.
The Centers for Medicare & Medicaid Services today released a memorandum and provider-specific guidance on complying with the interim final rule.